Global Blue Biotechnology Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Blue Biotechnology Market Research Report 2024
Blue biotechnology is the application of molecular biological methods to marine and freshwater organisms. These organisms are used for purposes like increasing seafood supply and safety, controlling the reproduction of dangerous water-borne organisms, and developing new drugs.
According to MRAResearch’s new survey, global Blue Biotechnology market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Blue Biotechnology market research.
Key companies engaged in the Blue Biotechnology industry include Aker BioMarine, Marinova, New England Biolabs, PML Applications, Sea Run Holdings, PICES, Donald Danforth Plant Science Center, Shell Marine Products and GeoMarine Biotechnologies, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Blue Biotechnology were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Blue Biotechnology market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Blue Biotechnology market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Aker BioMarine
Marinova
New England Biolabs
PML Applications
Sea Run Holdings
PICES
Donald Danforth Plant Science Center
Shell Marine Products
GeoMarine Biotechnologies
GlycoMar
Cellgen Biologicals
Nurture Aqua Technology
Samudra Biopharma
Sanosil Biotech
Segment by Type
Enzymes
Pharma Products
Bulk Chemicals
Biopolymers
Bio-Engineering
Genomics
Vaccine Development
Drug Discovery
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Blue Biotechnology report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global Blue Biotechnology market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Blue Biotechnology market research.
Key companies engaged in the Blue Biotechnology industry include Aker BioMarine, Marinova, New England Biolabs, PML Applications, Sea Run Holdings, PICES, Donald Danforth Plant Science Center, Shell Marine Products and GeoMarine Biotechnologies, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Blue Biotechnology were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Blue Biotechnology market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Blue Biotechnology market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Aker BioMarine
Marinova
New England Biolabs
PML Applications
Sea Run Holdings
PICES
Donald Danforth Plant Science Center
Shell Marine Products
GeoMarine Biotechnologies
GlycoMar
Cellgen Biologicals
Nurture Aqua Technology
Samudra Biopharma
Sanosil Biotech
Segment by Type
Enzymes
Pharma Products
Bulk Chemicals
Biopolymers
Segment by Application
Bio-Engineering
Genomics
Vaccine Development
Drug Discovery
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Blue Biotechnology report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source